INS and type 1 diabetes mellitus: Thus, this compelling need brings a sense of urgency to find a cure for diabetes that can not only halt the progression of autoimmunity in T1D and correct multiple immune dysfunctions in T2D, but also overcome the shortage of insulin-producing β-cells.